Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging

Chinese Medical Journal

Volumn 115, Issue 9, 2002, Pages 1363-1366

  Gong, Jingshan ^a,b   Xu, Jianmin ^a   Zhou, Kangrong ^a   Shen, Kuntang ^a,b  

^a SHENZHEN PEOPLE'S HOSPITAL   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Contrast media; Magnetic resonance; Manganese; Pancreas

Indexed keywords

MANGAFODIPIR; MANGANESE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; DRUG INFUSION; EXOCRINE CELL; FISTULA; IMAGE ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREAS JUICE; PANCREAS SECRETION; SIGNAL NOISE RATIO; VATER PAPILLA;

ANIMALS; CONTRAST MEDIA; DOGS; EDETIC ACID; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MANGANESE; PANCREAS; PYRIDOXAL PHOSPHATE;

EID: 0036743802     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Young SW, Simpson BB, Ratner AV, et al. MRI measurement of hepatocyte toxicity using the new MRI contrast agent dipyridoxal diphosphate, a mangese/pyridoxal 5-phosphate chelate. Magn Reson Med 1989;10:1-13.
2. Rummeny E, Stober M, Aicher KP, et al. Mn-DPDP as a hepatobiliary contrast agent in MR Imaging of liver tumors: first clinical results. Radiology 1990;177:326-326.
3. Elizodo G, Fretz CJ, Stark DD, et al. Preclincal hepatobiliary contrast, agent for MR imaging. Radiology 1991;178:73-78.
4. Lim KO, Stark DD, Leese PT, et al. Hepatobiliary MR imaging: first human experience with Mn-DPDP. Radioloy 1991;180:337-339.
5. Wang C, Gordon PB, Hustvedt SO, et al. MR imaging properties and harmacokinetics of MnDPDP in health volunteers. Acta Radiol 1997;38:665-676.
6. Gehl HB, Vorwerk D, Klosek C, et al. Pancreatic enhancement after low dose infusion of Mn-DPDP. Radiology 1991;180:337-339.
7. Gehl HB, Urhahn R, Bohndorf K, et al. Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience. Radiology 1993;186:795-798.
8. Wang C. Mangafodipir trisodium (Mn-DPDP)-enhanced magnetic resonance imaging of the liver and pancreas. Acta Radiol 1998; 415:1-31.
9. Mitchell DG, Outwater EK, Matteucci T, et al. Adrenal gland enhancement at MR imaging with Mn-DPDP. Radiology 1995; 194:783-787.
10. Hamm B, Vogl TJ, Branding G, et al. Focal liver lesions: MR imaging with Mn-DPDP-initial clinical results in 40 patients. Radiology 1992;182:167-174.
11. Coffin CM, Diche T, Mahfouz A, et al. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 1999;9:444-449.
12. Ni Y, Marchal G, Zhang X, et al. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization. Invest Radiol 1993;28:520-528.
13. Murakami T, Baron RL, Peterson MS, et al. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996;200:69-77.
14. Zhou KR, Gong JS, Zheng MS, et al. Pancreatic enhancement at t1-weighted MR Imaging with Mn-DPDP and comparing with dynamic gadolinium enhancement. AJR 2001;176:81-81.
15. Zhou KR, Gong JS, Zhen MS, et al. The role of Mn-DPDP imaging in pancreatic adenocarcinoma: comparing with dynamic gadolinium enhancement. Am J Roentgenol 2001;176:81-81.
16. Freeny PC, Stevenson GW. Alimentary tract radiology. 5th ed. St. Louis: Mosby; 1989:1017-1222.
17. Blume J, Palmie S, Aue B, et al. Pancreatic contrast enhancement with Mn-bis pyridoxal ethylene diamine diacetic acid and the influence of a hormonal stimulation of the pancreas in pigs. Acad Radiol 1994;1:253-260.